Disclosure Of First-Time Adoption [Text Block]

Zealand Pharma - Filing #5889383

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
Disclosure of first-time adoption [text block]
Disclosure of comparative information prepared under previous GAAP [text block]
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity
6,157,441,000 DKK
14,680,771,000 DKK
71,024,000 DKK
22,388,000 DKK
8,616,742,000 DKK
1,592,839,000 DKK
4,894,841,000 DKK
6,406,225,000 DKK
58,751,000 DKK
22,704,000 DKK
815,911,000 DKK
4,921,232,000 DKK
4,171,640,000 DKK
51,702,000 DKK
14,617,000 DKK
Comprehensive income
- DKK
- DKK
316,000 DKK
1,078,828,000 DKK
1,079,144,000 DKK
695,652,000 DKK
703,739,000 DKK
- DKK
8,087,000 DKK
- DKK
Profit (loss)
- DKK
- DKK
- DKK
1,078,828,000 DKK
1,078,828,000 DKK
703,739,000 DKK
703,739,000 DKK
- DKK
- DKK
- DKK

Talk to a Data Expert

Have a question? We'll get back to you promptly.